Apotex Calls for Clarity in CGT Designations

Drug Industry Daily
A A
One of Canada’s largest drug companies is urging the FDA to make clear when generics are eligible for competitive exclusivity.

To View This Article:

Login

Subscribe To Drug Industry Daily